| Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness JG Ryall, JD Schertzer, GS Lynch Biogerontology 9, 213-228, 2008 | 553 | 2008 |
| The NAD+-dependent SIRT1 deacetylase translates a metabolic switch into regulatory epigenetics in skeletal muscle stem cells JG Ryall, S Dell’Orso, A Derfoul, A Juan, H Zare, X Feng, D Clermont, ... Cell stem cell 16 (2), 171-183, 2015 | 533 | 2015 |
| Role of β-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease GS Lynch, JG Ryall Physiological reviews 88 (2), 729-767, 2008 | 491 | 2008 |
| Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest RJ Mills, DM Titmarsh, X Koenig, BL Parker, JG Ryall, GA Quaife-Ryan, ... Proceedings of the National Academy of Sciences 114 (40), E8372-E8381, 2017 | 417 | 2017 |
| Metabolic reprogramming of stem cell epigenetics JG Ryall, T Cliff, S Dalton, V Sartorelli Cell stem cell 17 (6), 651-662, 2015 | 304 | 2015 |
| Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells AH Juan, A Derfoul, X Feng, JG Ryall, S Dell'Orso, A Pasut, H Zare, ... Genes & development 25 (8), 789-794, 2011 | 234 | 2011 |
| Therapeutic approaches for muscle wasting disorders GS Lynch, JD Schertzer, JG Ryall Pharmacology & therapeutics 113 (3), 461-487, 2007 | 195 | 2007 |
| The orphan nuclear receptor, NOR-1, a target of β-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle MA Pearen, SA Myers, S Raichur, JG Ryall, GS Lynch, GEO Muscat Endocrinology 149 (6), 2853-2865, 2008 | 183 | 2008 |
| AMPK‐independent pathways regulate skeletal muscle fatty acid oxidation N Dzamko, JD Schertzer, JG Ryall, R Steel, SL Macaulay, S Wee, ... The Journal of physiology 586 (23), 5819-5831, 2008 | 166 | 2008 |
| The orphan nuclear receptor, NOR-1, is a target of β-adrenergic signaling in skeletal muscle MA Pearen, JG Ryall, MA Maxwell, N Ohkura, GS Lynch, GEO Muscat Endocrinology 147 (11), 5217-5227, 2006 | 155 | 2006 |
| Systemic administration of β2‐adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses JG Ryall, MN Sillence, GS Lynch British journal of pharmacology 147 (6), 587-595, 2006 | 146 | 2006 |
| β2‐Agonist administration reverses muscle wasting and improves muscle function in aged rats JG Ryall, DR Plant, P Gregorevic, MN Sillence, GS Lynch The Journal of physiology 555 (1), 175-188, 2004 | 133 | 2004 |
| Examination of ‘lipotoxicity’in skeletal muscle of high‐fat fed and ob/ob mice SM Turpin, JG Ryall, R Southgate, I Darby, AL Hevener, MA Febbraio, ... The Journal of physiology 587 (7), 1593-1605, 2009 | 121 | 2009 |
| A metabolic link to skeletal muscle wasting and regeneration R Koopman, CH Ly, JG Ryall Frontiers in physiology 5, 76427, 2014 | 115 | 2014 |
| β2-Adrenoceptor agonist fenoterol enhances functional repair of regenerating rat skeletal muscle after injury F Beitzel, P Gregorevic, JG Ryall, DR Plant, MN Sillence, GS Lynch Journal of Applied Physiology 96 (4), 1385-1392, 2004 | 114 | 2004 |
| A novel AMPK-dependent FoxO3A-SIRT3 intramitochondrial complex sensing glucose levels A Peserico, F Chiacchiera, V Grossi, A Matrone, D Latorre, M Simonatto, ... Cellular and Molecular Life Sciences 70, 2015-2029, 2013 | 113 | 2013 |
| The potential and the pitfalls of β-adrenoceptor agonists for the management of skeletal muscle wasting JG Ryall, GS Lynch Pharmacology & therapeutics 120 (3), 219-232, 2008 | 111 | 2008 |
| Comprehensive characterization of single-cell full-length isoforms in human and mouse with long-read sequencing L Tian, JS Jabbari, R Thijssen, Q Gouil, SL Amarasinghe, O Voogd, ... Genome biology 22, 1-24, 2021 | 107 | 2021 |
| Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue LJ Harcourt, JD Schertzer, JG Ryall, GS Lynch Neuromuscular Disorders 17 (1), 47-55, 2007 | 100 | 2007 |
| β2-Agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol JG Ryall, P Gregorevic, DR Plant, MN Sillence, GS Lynch American Journal of Physiology-Regulatory, Integrative and Comparative …, 2002 | 97 | 2002 |
Jonathan SchertzerProfessor, McMaster UniversityVerified email at mcmaster.ca
